MYELIN PROTEIN TRANSCRIPTS INCREASE IN EXPERIMENTAL DIABETIC NEUROPATHY

被引:7
|
作者
CONTI, AM
MALOSIO, ML
SCARPINI, E
DIGIULIO, AM
SCARLATO, G
MANTEGAZZA, P
GORIO, A
机构
[1] UNIV MILAN, DINO FERRARI CTR, INST NEUROL, I-20122 MILAN, ITALY
[2] UNIV MILAN, DEPT PHARMACOL CHEMOTHERAPY & MED TOXICOL, I-20122 MILAN, ITALY
关键词
EXPERIMENTAL DIABETIC NEUROPATHY; MYELIN PROTEIN; ALLOXAN-INDUCED DIABETES; NORTHERN BLOT; PERIPHERAL NERVE; P0; MBP;
D O I
10.1016/0304-3940(93)90294-U
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A Northern blot analysis of P0 and MBP myelin protein transcripts in the sciatic nerve from rats with alloxan-induced diabetes at two different time points is described. After 5 weeks of diabetes induction, only P0 mRNA is significantly increased by 39%, while at 14 weeks both P0 and MBP mRNA contents are markedly higher than controls. Insulin treatment normalizes glycemia levels, partially counteracts P0 mRNA increase at both stages of diabetes and delays MBP mRNA increase present only in chronic animals. We suggest that increased transcript levels of P0 and MBP in Schwann cells may represent a higher turnover of myelin sheath specific proteins in diabetic syndrome, as attempt to repair the hyperglycemia-induced nerve damage, which is partially prevented by insulin treatment.
引用
收藏
页码:203 / 206
页数:4
相关论文
共 50 条
  • [1] In situ hybridization study of myelin protein mRNA in rats with an experimental diabetic neuropathy
    Conti, AM
    Scarpini, E
    Malosio, ML
    DiGiulio, AM
    Baron, P
    Scarlato, G
    Mantegazza, P
    Gorio, A
    NEUROSCIENCE LETTERS, 1996, 207 (01) : 65 - 69
  • [2] Blockage of MLKL prevents myelin damage in experimental diabetic neuropathy
    Guo, Jia
    Guo, Zehui
    Huang, Yanju
    Ma, Suchen
    Yana, Bo
    Pana, Chenjie
    Jiang, Zhaodi
    Wang, Fengchao
    Zhang, Zhiyuan
    Da, Yuwei
    Wang, Xiaodong
    Ying, Zhengxin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (14)
  • [3] INCREASED TRANSCRIPTION OF MYELIN-SPECIFIC PROTEINS IN EXPERIMENTAL DIABETIC NEUROPATHY
    CONTI, AM
    MALOSIO, ML
    SCARPINI, E
    DIGIULIO, AM
    SCARLATO, G
    MANTEGAZZA, P
    GORIO, A
    NEUROLOGY, 1993, 43 (04) : A320 - A320
  • [4] EXPERIMENTAL DIABETIC NEUROPATHY
    MOORE, SA
    OCONNOR, BL
    PETERSON, RG
    ANATOMICAL RECORD, 1979, 193 (03): : 627 - 627
  • [5] Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy
    Calcutt, NA
    Allendoerfer, KL
    Mizisin, AP
    Middlemas, A
    Freshwater, JD
    Burgers, M
    Ranciato, R
    Delcroix, JD
    Taylor, FR
    Shapiro, R
    Strauch, K
    Dudek, H
    Engber, TM
    Galdes, A
    Rubin, LL
    Tomlinson, DR
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (04): : 507 - 514
  • [6] PROTEINS OF PERIPHERAL-NERVE MYELIN IN DIABETIC NEUROPATHY
    PALO, J
    SAVOLAINEN, H
    HALTIA, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1972, 16 (02) : 193 - +
  • [7] EXPERIMENTAL DIABETIC AUTONOMIC NEUROPATHY
    SCHMIDT, RE
    NELSON, JS
    JOHNSON, EM
    AMERICAN JOURNAL OF PATHOLOGY, 1981, 103 (02): : 210 - 225
  • [8] Experimental diabetic neuropathy: an update
    A. A. F. Sima
    K. Sugimoto
    Diabetologia, 1999, 42 : 773 - 788
  • [9] Comparative ultrastructure of feline diabetic neuropathy, experimental galactose neuropathy and human diabetic neuropathy
    Powell, HC
    Shelton, GD
    Mizisin, AP
    BRAIN PATHOLOGY, 1997, 7 (03) : 1019 - 1019
  • [10] DIABETIC NEUROPATHY - HUMAN AND EXPERIMENTAL
    THOMAS, PK
    DRUGS, 1986, 32 : 36 - 42